Azithromycin and risk of COPD exacerbations in patients with and without Helicobacter pylori. [electronic resource]
Producer: 20180614Description: 109 p. digitalISSN:- 1465-993X
- Aged
- Anti-Bacterial Agents -- adverse effects
- Antibodies, Bacterial -- blood
- Azithromycin -- adverse effects
- Biomarkers -- blood
- C-Reactive Protein -- metabolism
- Disease Progression
- Disease-Free Survival
- Female
- Helicobacter Infections -- blood
- Helicobacter pylori -- drug effects
- Humans
- Kaplan-Meier Estimate
- Lung -- drug effects
- Male
- Middle Aged
- Proportional Hazards Models
- Pulmonary Disease, Chronic Obstructive -- diagnosis
- Receptors, Tumor Necrosis Factor, Type II -- blood
- Risk Factors
- Serologic Tests
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.